中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态招聘中
赞助商
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

关键词

抽象

The purpose of this study is to collect clinical data, blood samples, and self reported symptoms of peripheral neuropathy from Chinese patients with breast cancer after treatment with taxanes. This data will be used to develop predictive markers for neuropathy.

日期

最后验证: 02/29/2020
首次提交: 08/14/2019
提交的预估入学人数: 08/22/2019
首次发布: 08/27/2019
上次提交的更新: 03/25/2020
最近更新发布: 03/29/2020
实际学习开始日期: 08/22/2019
预计主要完成日期: 11/30/2020
预计完成日期: 11/30/2020

状况或疾病

Breast Cancer

干预/治疗

Other: Patient Questionnaires

Other: Blood Collection

-

手臂组

干预/治疗
Patients with CIPN
Patients with peripheral neuropathy after treatment with taxanes
Patients without CIPN
Patients treated with taxanes and don't develop will be enrolled to this cohort and matched to a specified subject with neurotoxicity based on age, tumor stage, chemotherapy regimen or total taxane dosage

资格标准

有资格学习的年龄 16 Years 至 16 Years
有资格学习的性别Female
取样方式Non-Probability Sample
接受健康志愿者
标准

Inclusion Criteria:

- Diagnosis of breast cancer

- Females aged 16 and older

- Planning to receive or previous treated with taxanes

Exclusion Criteria:

- Poorly controlled or insulin-dependent diabetes or other condition likely to predispose to neurotoxicity

结果

主要结果指标

1. Total score from the FACT-GOG-Ntx questionnaire [Up to 2 years]

Total score from the FACT-GOG-Ntx questionnaire for peripheral neuropathy, ranging from 0-44,higher value represents a worse outcome

次要成果指标

1. Predictive value of genetic variants for the development of neuropathy [In the two weeks before start treatment]

SNPs related to peripheral neuropathy

2. Total score from the EORTC QLQ - CIPN20 questionnaire [Up to 2 years]

Total score from the EORTC QLQ - CIPN20 questionnaire for peripheral neuropathy, ranging from 20-80,higher value represents a worse outcome

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge